𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adverse drug reaction reporting

✍ Scribed by William Bill Springfield


Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
124 KB
Volume
72
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Spontaneous reporting of adverse drug re
✍ Pascale Tubert-Bitter; FranΓ§oise Haramburu; Bernard Begaud; Anicet Chaslerie; Er πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 123 KB

A survey among Bordeaux pharmacovigilance centre `users' and `non-users' was conducted in Aquitaine, France. Two hundred physicians having reported to the centre at least one adverse drug reaction (ADR) during the past 3 years were matched to a randomly selected sample of 400 physicians who did not

Regional reporting of adverse drug react
✍ Walter J. Swoboda; Martin GΓΆttler; Joerg Hasford πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

The use of drugs is always accompanied by the risk of adverse drug reactions (ADRs) and adverse events (AE). Generally physicians, pharmaceutical manufacturers, and pharmacists use a paper-based form for sending spontaneous ADR and AE reports to the national drug regulatory authority. Besides underr

US Adverse Drug Reaction Surveillance 19
✍ Gerald A. Faich πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 436 KB

Adverse drug reaction surveillance conducted by the US Federal Food and Drug Administration (FDA) is important for detecting new safety information about pharmaceuticals. FDA has sought to stimulate reporting of reactions by practitioners and manufacturers. Over the five years from 1989 to 1993, rep

Reasons for Reporting Adverse Drug React
✍ Cecilia Biriell; I. Ralph Edwards πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 1 views

A pilot study was made to explore positive reasons for physicians and pharmacists taking time to report adverse reactions, rather than reasons for failing to report which has been studied by many authors. The 34 national drug monitoring centres participating in the international programme at the tim